Notch, a unifying target in T-cell acute lymphoblastic leukemia?

Trends in Molecular Medicine

Volumn 9, Issue 1, 2003, Pages 30-35

  Screpanti, Isabella ^a   Bellavia, Diana ^a   Campese, Antonio F ^a   Frati, Luigi ^b   Gulino, Alberto ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b IRCCS NEUROMED   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NOTCH RECEPTOR; NOTCH3 RECEPTOR; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E2A; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENE OVEREXPRESSION; GENE TARGETING; GENETIC CONSERVATION; LEUKEMOGENESIS; REVIEW; SIGNAL TRANSDUCTION; T CELL LEUKEMIA;

ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; DNA-BINDING PROTEINS; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, T-CELL; MEMBRANE PROTEINS; MODELS, BIOLOGICAL; NF-KAPPA B; PROTO-ONCOGENE PROTEINS; RECEPTOR, NOTCH1; RECEPTORS, CELL SURFACE; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 0037248329     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4914(02)00003-5     Document Type: Review

References (47)

1. Staudt, L.M. (2002) It's ALL in the diagnosis. Cancer Cell 1,109-110
2. Ferrando, A.A. and Look, A.T. (2000) Clinical implications of recurring chromosomal and associated molecular abnormalities in acute lymphoblastic leukemia. Semin. Hematol. 37, 381-395
3. Ferrando, A.A. et al. (2002) Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell 1, 75-87
4. Bellavia, D. et al. (2002) Combined expression of pTα and Notch3 in T cell leukemia identifies the requirement of preTCR for leukemo-genesis. Proc. Natl Acad. Sci. USA 99, 3788-3793
5. Joutel, A. et al. (2000) De novo mutation in the Notch3 gene causing CADASIL. Ann. Neurol. 47, 388-391
6. Hicks, C. et al. (2000) Fringe differentially modulates Jagged1 and Delta1 signaling through Notch1 and Notch2. Nat. Cell Biol. 2, 515-520
7. Artavanis-Tsakonas, S. et al. (1999) Notch signaling: cell fate control and signal integration in development. Science 284, 770-776
8. Mumm, S.J. and Kopan, R. (2000) Notch signalling: from outside in. Dev. Biol. 228, 151-165
9. Kadesh, T. (2000) Notch signaling: a dance of proteins changing partners. Exp. Cell Res. 260, 1-8
10. Beatus, P. et al. (2001) The origin of the ankyrin repeat region in Notch intracellular domains is critical for regulation of HES promoter activity. Mech. Dev. 104, 3-20
11. Fryer, C.J. et al. (2002) Mastermind mediates chromatin-specific transcription and turnover of the Notch enhancer complex. Genes Dev. 16, 1397-1411
12. Jeffries, S. et al. (2002) Characterization of a high-molecular-weight Notch complex in the nucleus of Notch(ic)-transformed RKE cells and in a human T-cell leukemia cell line. Mol. Cell. Biol. 22, 3927-3941
13. Deftos, M.L. et al. (2000) Notch1 signaling promotes the maturation of CD4 and CD8 SP thymocytes. Immunity 13, 73-84
14. Bellavia, D. et al. (2000) Constitutive activation of NF-κB and T-cell leukemia/lymphoma in Notch3 transgenic mice. EMBO J. 19, 3337-3348
15. French, M.B. et al. (2002) Transgenic expression of numb inhibits notch signaling in immature thymocytes but does not alter T cell fate specification. J. Immunol. 168, 3173-3180
16. Giniger, E. (1998) A role for Abl in Notch signaling. Neuron 20, 667-681
17. Jeffries, S. and Capobianco, A.J. (2000) Neoplastic transformation by Notch requires nuclear localization. Mol. Cell. Biol. 20, 3928-3941
18. Dumont, E. et al. (2000) Neoplastic transformation by Notch is independent of transcriptional activation by RBP-J signalling. Oncogene 19, 556-561
19. Aster, J.C. et al. (2000) Essential roles for ankyrin repeat and transactivation domains in induction of T-cell leukemia by Notch1. Mol. Cell. Biol. 20, 7505-7515
20. Fowlkes, B.J. and Robey, E.A. (2002) A reassessment of the effect of activated Notch1 on CD4 and CD8 T cell development. J. Immunol. 169, 1817-1821
21. Lee, J.S. et al. (1999) Murine leukemia provirus-mediated activation of the Notch1 gene leads to induction of HES-1 in a mouse T lymphoma cell line, DL-3. FEBS Lett. 455, 276-280
22. Kawamata, S. et al. (2002) Overexpression of the Notch target genes Hes in vivo induces lymphoid and myeloid alterations. Oncogene 21, 3855-3863
23. Izon, D.J. et al. (2002) Deltex1 redirects lymphoid progenitors to the B cell lineage by antagonizing Notch1. Immunity 16, 231-243
24. Tomita, K. et al. (1999) The bHLH gene Hes1 is essential for expansion of early T cell precursors. Genes Dev. 13, 1203-1210
25. Rothenberg, E.V. (2001) Notchless T cell maturation? Nat. Immunol. 2, 189-190
26. Felli, M.P. et al. (1999) Expression pattern of Notch1, 2 and 3 and Jagged1 and 2 in lymphoid and stromal thymus components: distinct ligand-receptor interactions in intrathymic T cell development. Int. Immunol. 11, 1017-1025
27. Radtke, F. et al. (1999) Deficient T cell fate specification in mice with an induced inactivation of Notch1. Immunity 10, 547-558
28. Allman, D. et al. (2001) Separation of Notch1 promoted lineage commitment and expansion/transformation in developing T cells. J. Exp. Med. 194, 99-106
29. Wolfer, A. et al. (2002) Inactivation of Notch1 impairs VDJβ rearrangement and allows pre-TCR-independent survival of early αβ lineage thymocytes. Immunity 16, 869-879
30. Ellisen, L-V. et al. (1991) TAN-1, the human homolog of the Drosophila Notch gene, is broken by chromosomal translocations in T lympho-blastic neoplasm. Cell 66, 649-661
31. Pear, W.S. et al. (1996) Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated Notch alleles. J. Exp. Med. 183, 2283-2291
32. Rohn, J.L. et al. (1996) Transduction of Notch2 in feline leukemia virus-induced thymic lymphoma. J. Virol. 70, 8071-8080
33. Reizis, B. and Leder, P. (2002) Direct induction of T lymphocyte-specific gene expression by the mammalian Notch signaling pathway. Genes Dev. 16, 295-300
34. Voll, R.E. et al. (2000) NF-κB activation by pre-T Cell receptor serves as a selective survival signal in T lymphocyte development. Immunity 13, 677-689
35. 2+ mobilization and activation of NF-κB and NFAT. Nat. Immun. 2, 403-409
36. Orlowski, R.Z. and Baldwin, A.S. Jr (2002) NF-κB as a therapeutic target in cancer. Trends Mol. Med. 8, 385-389
37. Oswald, F. et al. (1998) NFκB2 is a putative target gene of activated Notch1 via RBP-Jκ. Mol. Cell. Biol. 18, 2077-2088
38. Guan, E. et al. (1996) T cell leukemia-associated human Notch/Translocation-associated Notch homologue has IκB-like activity and physically interacts with nuclear factor-κB proteins in T cells. J. Exp. Med. 183, 2025-2032
39. Wang, J. et al. (2001) Human Notch1 inhibits NF-κB activity in the nucleus through a direct interaction involving a novel domain. J. Immunol. 167, 289-295
40. Ordentlich, P. et al. (1998) Notch inhibition of E47 supports the existence of a novel signaling pathway. Mol. Cell. Biol. 18, 2230-2239
41. Quong, M.W. et al. (2002) E protein function in lymphocyte development. Annu. Rev. Immunol. 20, 301-322
42. Takeuchi, A. et al. (2001) E2A and HEB activate the pre-TCRα promoter during immature T cell development. J. Immunol. 167, 2157-2163
43. Engel, I. and Murre, C. (2002) Disruption of pre-TRC expression accelerates lymphomagenesis in E2A-deficient mice. Proc. Natl Acad. Sci. U.S.A. 99, 11322-11327
44. Herblot, S. et al. (2000) SCL and LMO1 alter thymocyte differentiation:inhibition of E2A-HEB function and pre-Tα chain expression. Nat. Immun. 1, 138-143
45. Petit, A. et al. (2001) New protease inhibitors prevent γ-secretase-mediated production of Aβ40/42 without affecting Notch cleavage. Nat. Cell Biol. 3, 507-511
46. Jaleco, A.C. et al. (2001) Differential effects of Notch ligands Delta-1 and Jagged-1 in human lymphoid differentiation. J. Exp. Med. 194, 991-1001
47. Yan, X.-Q. et al. (2001) A novel Notch ligand, Dll4, induces T cell leukemia/lymphoma when overexpressed in mice by retroviral-mediated gene transfer. Blood 98, 3793-3799